These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 310945)

  • 21. Clinical and laboratory evaluation of cefamandole in infants and children.
    Rodriguez WJ; Ross S; Khan WN; Goldenberg R
    J Infect Dis; 1978 May; 137 Suppl():S150-S154. PubMed ID: 306402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapy of serious infections with cefamandole.
    Parry MF; Goldberger MJ; Neu HC
    Infection; 1978; 6(5):236-40. PubMed ID: 365776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum and tissue concentrations of cefoxitin and cefamandole in women undergoing hysterectomy.
    French MA; Quintiliani R; Nightingale CH; Russo JN
    Obstet Gynecol; 1983 Jan; 61(1):42-7. PubMed ID: 6823348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cefamandole, cefuroxime and cefoxitin.
    Drug Ther Bull; 1979 Apr; 17(9):35-6. PubMed ID: 446269
    [No Abstract]   [Full Text] [Related]  

  • 25. In vivo inoculum effect and resistance selection with cefamandole and cefoxitin against Enterobacter cloacae in mice.
    Miller AK; Celozzi E; Pelak BA; Birnbaum J; Stapley EO
    J Antimicrob Chemother; 1980 Nov; 6(6):804-6. PubMed ID: 7002900
    [No Abstract]   [Full Text] [Related]  

  • 26. [A new cephalosporin: cefoxitin].
    Brion M; Mouton Y; Beaucaire G; Fourrier A
    Lille Med; 1980 May; 25(5):240-3. PubMed ID: 7392776
    [No Abstract]   [Full Text] [Related]  

  • 27. [3 new cephalosporins: cefamandole, cefuroxime, cefoxitin].
    Mirimanoff RO; Héraïef E
    Rev Med Suisse Romande; 1981 Dec; 101(12):963-8. PubMed ID: 7342276
    [No Abstract]   [Full Text] [Related]  

  • 28. Cefamandole nafate therapy of respiratory tract, skin, and soft tissue infections in 74 patients.
    Perkins RL; Fass RJ; Warner JF; Prior RB; File TM; Tight RR; Gardner WG; Ruiz DE; Slama TG
    J Infect Dis; 1978 May; 137 Suppl():S110-S118. PubMed ID: 418126
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical failure of cefamandole in the treatment of Hemophilus influenzae bacteremia.
    Olsson JM; Keyserling H; Feldman WE
    Clin Pediatr (Phila); 1982 Apr; 21(4):244-5. PubMed ID: 6978225
    [No Abstract]   [Full Text] [Related]  

  • 30. Cefamandole in the treatment of serious bone and joint diseases.
    Levine LR
    Scand J Infect Dis Suppl; 1980; suppl 25():89-93. PubMed ID: 7010542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of R-plasmid mediated beta-lactamase production on the therapeutic efficacy of cefoxitin and cefamandole in experimental chemotherapy.
    Marre R; Schulz E; Freiesleben H
    J Antimicrob Chemother; 1980 Sep; 6(5):633-8. PubMed ID: 6997259
    [No Abstract]   [Full Text] [Related]  

  • 32. Cefamandole for treatment of obstetrical and gynecological infections.
    Cunningham FG; Gilstrap LC; Kappus SS
    Scand J Infect Dis Suppl; 1980; suppl 25():75-82. PubMed ID: 7010540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous treatment of systemic infections in 20 patients with cefoxitin sodium.
    Laplante L; Bastien E; Giroux Y; Girard R
    J Antimicrob Chemother; 1978 Jul; 4(B):219-22. PubMed ID: 357391
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of cefoxitin sodium in difficult-to-treat infections.
    Ramachandran Nair S; Cherubin CE
    J Antimicrob Chemother; 1978 Jul; 4(B):167-78. PubMed ID: 357383
    [No Abstract]   [Full Text] [Related]  

  • 35. [In vitro sensitivity of hospital-isolated pathogenic bacterial strains to 4 different cephalosporins: cephaloridine, cefotaxime, cefoxitin, cefonicid].
    Rosina M; Mauri J; Germiniani R; Mastropasqua E; Figini G
    Minerva Chir; 1986 Aug; 41(15-16):1347-51. PubMed ID: 3774182
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinico-microbiologic bases for the use of new cephalosporins].
    De Bac C; Mascellino MT; Nuti M
    Minerva Med; 1982 Apr; 73(15):899-903. PubMed ID: 6979006
    [No Abstract]   [Full Text] [Related]  

  • 37. Ceftizoxime compared with cefamandole for treatment of soft tissue infections.
    Mills J; Slutkin G; Klein D; Schecter W
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():273-9. PubMed ID: 6296020
    [No Abstract]   [Full Text] [Related]  

  • 38. ["In vitro" activity of cefamandole, cefalotin, cefoxitin and cefuroxim against enterobacteria and Staphylococcus aureus isolated in hospital (author's transl)].
    Thabaut A; Durosoir JL; Saliou P
    Pathol Biol (Paris); 1979 Dec; 27(10):649-54. PubMed ID: 395496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cefonicid sodium (Monocid).
    Med Lett Drugs Ther; 1984 Aug; 26(667):71-2. PubMed ID: 6379400
    [No Abstract]   [Full Text] [Related]  

  • 40. Cefamandole--a status report based on the symposium on cefamandole.
    Moellering RC
    J Infect Dis; 1978 May; 137 Suppl():S190-S194. PubMed ID: 650002
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.